1. Home
  2. PRTA vs CCIX Comparison

PRTA vs CCIX Comparison

Compare PRTA & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • CCIX
  • Stock Information
  • Founded
  • PRTA 2012
  • CCIX 2023
  • Country
  • PRTA Ireland
  • CCIX United States
  • Employees
  • PRTA N/A
  • CCIX N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • CCIX
  • Sector
  • PRTA Health Care
  • CCIX
  • Exchange
  • PRTA Nasdaq
  • CCIX Nasdaq
  • Market Cap
  • PRTA 472.1M
  • CCIX 386.8M
  • IPO Year
  • PRTA N/A
  • CCIX 2024
  • Fundamental
  • Price
  • PRTA $8.20
  • CCIX $10.55
  • Analyst Decision
  • PRTA Buy
  • CCIX
  • Analyst Count
  • PRTA 10
  • CCIX 0
  • Target Price
  • PRTA $14.86
  • CCIX N/A
  • AVG Volume (30 Days)
  • PRTA 1.2M
  • CCIX 41.6K
  • Earning Date
  • PRTA 08-04-2025
  • CCIX 11-07-2013
  • Dividend Yield
  • PRTA N/A
  • CCIX N/A
  • EPS Growth
  • PRTA N/A
  • CCIX N/A
  • EPS
  • PRTA N/A
  • CCIX 0.28
  • Revenue
  • PRTA $10,341,000.00
  • CCIX N/A
  • Revenue This Year
  • PRTA N/A
  • CCIX N/A
  • Revenue Next Year
  • PRTA $389.77
  • CCIX N/A
  • P/E Ratio
  • PRTA N/A
  • CCIX $37.30
  • Revenue Growth
  • PRTA N/A
  • CCIX N/A
  • 52 Week Low
  • PRTA $4.32
  • CCIX $10.00
  • 52 Week High
  • PRTA $22.83
  • CCIX $11.66
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.73
  • CCIX 50.86
  • Support Level
  • PRTA $8.05
  • CCIX $10.51
  • Resistance Level
  • PRTA $8.73
  • CCIX $10.57
  • Average True Range (ATR)
  • PRTA 0.38
  • CCIX 0.04
  • MACD
  • PRTA -0.05
  • CCIX 0.01
  • Stochastic Oscillator
  • PRTA 47.62
  • CCIX 55.56

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About CCIX Churchill Capital Corp IX Ordinary Shares

Churchill Capital Corp IX is a blank check company.

Share on Social Networks: